Wang Yin

1.5k total citations
23 papers, 1.2k citations indexed

About

Wang Yin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wang Yin has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Wang Yin's work include Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Wang Yin is often cited by papers focused on Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Wang Yin collaborates with scholars based in China, Australia and United States. Wang Yin's co-authors include Wei Duan, Tao Wang, Yingchun Hou, Phuong H.L. Tran, Yong Li, Dongxi Xiang, Thao T.D. Tran, Yumei Zhang, Lingxue Kong and Sarah Shigdar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Oncogene.

In The Last Decade

Wang Yin

22 papers receiving 1.2k citations

Peers

Wang Yin
Yan Hu China
Yong Zhu China
Calvin R. Justus United States
Nishant Gandhi United States
Janani Panneerselvam United States
Wang Yin
Citations per year, relative to Wang Yin Wang Yin (= 1×) peers Michael Lykke Hvam

Countries citing papers authored by Wang Yin

Since Specialization
Citations

This map shows the geographic impact of Wang Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Yin more than expected).

Fields of papers citing papers by Wang Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Yin. The network helps show where Wang Yin may publish in the future.

Co-authorship network of co-authors of Wang Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Wang Yin. A scholar is included among the top collaborators of Wang Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang Yin. Wang Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yi, et al.. (2025). Application of non‑coding RNAs in tumors (Review). Molecular Medicine Reports. 31(6). 1–12.
2.
Yin, Wang, et al.. (2024). Functionalized Blood Small Extracellular Vesicles with Polydopamine Nanoparticles for Chemo-Thermal Therapy. ACS Applied Materials & Interfaces. 16(27). 34561–34577. 2 indexed citations
3.
Liu, Shuji, Yue Zhang, Yihui Chen, et al.. (2024). Isolation and Purification of Protamine from the Cultured Takifugu flavidus and Its Physicochemical Properties. Molecules. 29(1). 263–263. 5 indexed citations
4.
Yin, Wang, Cuong Viet Pham, Tao Wang, et al.. (2022). Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin. Biomolecules. 12(11). 1623–1623. 22 indexed citations
5.
Liu, Yifeng, Yi‐Hao Chen, Zhen Liu, et al.. (2022). Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells. Biomedicine & Pharmacotherapy. 150. 112998–112998. 33 indexed citations
6.
Pham, Cuong Viet, Yumei Zhang, Roberto A. Barrero, et al.. (2021). Bovine extracellular vesicles contaminate human extracellular vesicles produced in cell culture conditioned medium when ‘exosome-depleted serum’ is utilised. Archives of Biochemistry and Biophysics. 708. 108963–108963. 16 indexed citations
7.
Yin, Wang, Dongxi Xiang, Tao Wang, et al.. (2021). The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells. Scientific Reports. 11(1). 10791–10791. 47 indexed citations
8.
Xiang, Dongxi, Qian Chen, Wang Yin, et al.. (2020). Aptamer-guided extracellular vesicle theranostics in oncology. Theranostics. 10(9). 3849–3866. 64 indexed citations
9.
Pan, Hua, Xiaoqing Wang, Weiqiang Huang, et al.. (2020). Interferon-Induced Protein 44 Correlated With Immune Infiltration Serves as a Potential Prognostic Indicator in Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 10. 557157–557157. 21 indexed citations
10.
Yang, Lijun, Donglin Han, Qi Zhan, et al.. (2019). Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy. Theranostics. 9(25). 7680–7696. 76 indexed citations
11.
Wang, Tao, Wang Yin, Yumei Zhang, et al.. (2019). A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate. Human Gene Therapy Methods. 30(1). 1–16. 34 indexed citations
12.
Tran, Phuong H.L., Tao Wang, Wang Yin, et al.. (2019). Aspirin-loaded nanoexosomes as cancer therapeutics. International Journal of Pharmaceutics. 572. 118786–118786. 85 indexed citations
13.
Tran, Phuong H.L., Tao Wang, Wang Yin, et al.. (2019). Development of a nanoamorphous exosomal delivery system as an effective biological platform for improved encapsulation of hydrophobic drugs. International Journal of Pharmaceutics. 566. 697–707. 64 indexed citations
14.
Wang, Tao, Dongxi Xiang, Wang Yin, et al.. (2017). Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells. Scientific Reports. 7(1). 5898–5898. 44 indexed citations
15.
Xiang, Dongxi, Sarah Shigdar, Andrew G. D. Bean, et al.. (2017). Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery. Theranostics. 7(17). 4071–4086. 74 indexed citations
16.
Wang, Tao, Sarah Shigdar, Hadi Al Shamaileh, et al.. (2016). Challenges and opportunities for siRNA-based cancer treatment. Cancer Letters. 387. 77–83. 93 indexed citations
17.
Yin, Wang, Paraskevi Gkeka, Julian E. Fuchs, Klaus R. Liedl, & Zoe Cournia. (2016). DPPC-cholesterol phase diagram using coarse-grained Molecular Dynamics simulations. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1858(11). 2846–2857. 109 indexed citations
18.
Zhang, Zhenyu, Jiajun Cai, Jin Tae Hong, et al.. (2016). Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation. Medical Oncology. 33(9). 99–99. 9 indexed citations
19.
Wang, Xiaorong, Xue Yang, Wang Yin, et al.. (2015). 5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene. Oncology Reports. 35(3). 1375–1384. 17 indexed citations
20.
Guerrero, Paola A., Wang Yin, Laura Camacho, & Philippe Marchetti. (2014). Oncogenic role of Merlin/NF2 in glioblastoma. Oncogene. 34(20). 2621–2630. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026